BioHarvest Sciences Inc. Appoints Two Top Ranked Law Firms in the US and Canada to Pursue Regulatory Approvals of Its Upcoming Cannabis and Hemp Products Biotech Investing
Aurinia Pharmaceuticals to Release Second Quarter 2021 Financial Results on August 5, 2021 Biotech Investing
New Data Presented on the Safety and Efficacy of Investigational AGN-190584 as a Potential Novel Treatment for Presbyopia, a Common and Progressive Eye Condition Biotech Investing
DALVANCE® Receives FDA Approval to Treat Acute Bacterial Skin and Skin Structure Infections in Pediatric Patients Biotech Investing
Lexaria’s DehydraTECH Significantly Enhances Delivery of Colchicine in Study VIRAL-A20-3 Cannabis Investing News
Venetoclax Granted US FDA Breakthrough Therapy Designation in Higher Risk Myelodysplastic Syndrome Biotech Investing
Aptose to Report Second Quarter 2021 Financial Results and Hold Conference Call on Tuesday, August 3, 2021 Biotech Investing
Allergan, an AbbVie Company, to Present New Data from its Leading Eye Care Portfolio at the 2021 ASCRS Annual Meeting Biotech Investing
